Vascular Closure Device Market Key Insights Profiling Companies and Growth Strategies 2030

The global "Vascular Closure Device Market" is expected to reach US$ 2,804.55 million in 2030 from US$ 1,620.44 million in 2022. The market is estimated to grow with a CAGR of 7.1% from 2022 to 2030.

The key factors driving the market's growth include increasing prevalence of cardiovascular diseases and burgeoning demand for minimally invasive devices. However, risk of infection related to vascular closure devices hinder the market growth.

Get a Sample PDF of report @: https://www.premiummarketinsights.com/sample/TIP00000865?utm_source=OpenPr&utm_medium=10688

Companies Profiled in this report includes:

• Cordis Corp
• Transluminal Technologies LLC
• Vasorum Ltd
• Haemonetics Corp
• Abbott Laboratories
• Becton Dickinson and Co
• Cardinal Health Inc
• ENDOCOR GmbH & CO KG
• Medtronic Plc
• Teleflex Inc

Market Opportunities of Vascular Closure Device Market

Emerging countries such as India, China, Argentina, Brazil, UAE, and South Africa are expected to offer significant growth opportunities for vascular closure devices market players due to rising disposable incomes, expanding patient population, increasing R&D activities, improving healthcare infrastructure, growing CVD awareness, and relatively lenient guidelines compared to developed countries. According to the World Economic Forum, as of 2022, Russia, Brazil, China, India, and South Africa collectively accounted for a third of total global health spending. As per the World Bank, health spending in India and China increased by 3.01% and 5.35%, respectively, from 2018 to 2019.

Also, there has been an upsurge in heart failure cases over the past decade in emerging markets, which has resulted in a large number of cardiovascular disease-related deaths. As per the India Brand Equity Foundation, hospitals contribute to ~70% of the revenue of the healthcare sector in India. In China, the number of private hospitals reached up to 36,000 in 2022. Moreover, the private hospitals account for ~57% of total number of hospitals in the country. The number of surgical centers and hospitals in developing markets is estimated to grow due to rising healthcare spending and a surge in the target patient population. Therefore, the development of healthcare facilities in developing economies along with a surge in a number of hospitals would propel the awareness and adoption of vascular closure devices in emerging economies. Further, vast competition in developed or matured markets encourages vascular closure device manufacturers to focus on developing markets, which is likely to offer growth opportunities for vascular closure device providers to attain a significant position in the market.

Buy this report @: https://www.premiummarketinsights.com/buy/TIP00000865?utm_source=OpenPr&utm_medium=10688

Vascular Closure Device Market Segmentation:

By Product Type:
• Active Approximators
• Passive Approximators
• External Hemostatic Devices

Access:
• Femoral Access
• Radial Access

Procedure:
• Interventional Cardiology
• Interventional Radiology
• Endovascular Surgery

End User:
• Hospitals
• Ambulatory Surgical Centers

Vascular Closure Device Market: Segmental Overview

The vascular closure device market, by product type, is segmented into active approximators, passive approximators, and external hemostatic devices. The passive approximators segment held the largest share of the market in 2022, and it is anticipated to register the highest CAGR in the market during 2022-2030. Passive approximators deploy a plug, sealant, or gel at the arteriotomy site instead of closing it via an active mechanism. Unlike active approximators, passive approximators do not require any additional closure mechanisms, such as sutures or clips, once deployed. Passive approximators typically consist of biodegradable or resorbable components that facilitate the natural clotting process and promote the formation of a stable blood clot at a puncture site.
Based on access, the vascular closure device market has been segmented into femoral access and radial access. The femoral access segment held a larger share of the market in 2022. The radial access segment is expected to register a higher CAGR in the market during 2022-2030. Femoral access involves accessing blood vessels through the femoral artery in the groin area, while radial access involves accessing blood vessels through a radial artery in the wrist. The radial approach has gained popularity in recent years due to its advantages such as reduced risk of complications, including bleeding and hematoma, compared to femoral access.

Contact Us:

If you have any queries about this report or if you would like further information, please
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email: sales@premiummarketinsights.com

About Us:

Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost-effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.
Premium Market Insights has an extensive coverage of industry reports, company reports and country reports across all industries. In case your research needs are not met by syndicated reports offered by leading publishers, we can help you by offering a customized research solution by liaising with different research agencies saving your valuable time and money.
We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider. We also offer enterprise subscriptions which provide significant cost savings to our clients.

This release was published on openPR.